| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Yong-Jun Huh last filed a Form 4 in July 2024, as Director at ARTV. Yong-Jun Huh's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 1,260,512 shares of ARTV. Net of sales, the ARTV filings show accumulation of 2,083,332 shares.
Yong-Jun Huh has 1 Form 4 filing on record in July 2024, as Director at Artiva Biotherapeutics (ARTV), 2024.
The 8 reported transactions were 4 conversions, 2 other transactions and 2 open-market purchases.
Counted by filing, the open-market trades come to 1 purchase worth about $25.0M and no sales.
The only open-market purchase was 2,083,332 shares of ARTV at an average $12.00 on July 22, 2024, about $25.0M. Twelve months later ARTV was down 78%.
Shares as reported in the last Form 4 for each company; the most recent is from July 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 22, 2024 | ARTV Artiva Biotherapeutics, Inc. | Director | Buy | 2,083,332 | $12.00 | $24,999,984.00 | -253.2% | -11.0% | -78.1% |